Sands Capital Alternatives, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 13, 2025), Sands Capital Alternatives, LLC reported 20 stock positions worth $456.4 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 25.2% of the portfolio, followed by Klaviyo Class A (KVYO, 21.3%) and Beta Bionics (BBNX, 15.5%). Compared with Q2 2025, it opened 1 new position, added to 1 and reduced 2. The biggest buy was Samsara Class A (IOT, shares +37%) and the biggest sale DoorDash Class A (DASH, shares −76%).
- Most Recent 13F
- Q2 2026
- Location
- ARLINGTON, VA
- CIK
- 0001846444
- Portfolio Value
- $456.4M (Q3 2025)
- SEC Filing
- 0001846444-25-000022 ↗ filed Nov 13, 2025
Holdings Value
Holdings 20 stocks · $456.4M
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 25.17% | 7,175,434 | $114.9M | No change |
| KVYO Klaviyo Inc. Class A | 21.33% | 3,515,065 | $97.3M | No change |
| BBNX Beta Bionics Inc. | 15.54% | 3,570,113 | $70.9M | No change |
| CPNG Coupang Inc. | 5.61% | 795,006 | $25.6M | Reduce -6.4% |
| DASH DoorDash Inc. Class A | 5.37% | 90,142 | $24.5M | Reduce -76.3% |
| IOT Samsara Inc. Class A | 4.89% | 598,914 | $22.3M | Add +36.6% |
| IKT Inhibikase Therapeutics Inc. | 3.89% | 10,950,000 | $17.7M | No change |
| DDOG Datadog Inc. Class A | 3.70% | 118,707 | $16.9M | No change |
| MNDY Monday.com Ltd. | 2.48% | 58,336 | $11.3M | No change |
| TARS Tarsus Pharmaceuticals Inc. | 2.21% | 170,000 | $10.1M | No change |
| CRWD CrowdStrike Holdings Inc. Class A | 1.68% | 15,615 | $7.7M | No change |
| SNOW Snowflake Inc. | 1.33% | 27,005 | $6.1M | No change |
| ABOS Acumen Pharmaceuticals Inc. | 1.28% | 3,417,075 | $5.8M | No change |
| TOST Toast Inc. Class A | 1.25% | 156,604 | $5.7M | No change |
| TXG 10X Genomics Inc. Class A | 1.23% | 481,770 | $5.6M | No change |
| BIOA Bioage Labs Inc. | 1.01% | 786,353 | $4.6M | No change |
| ACRV Acrivon Therapeutics Inc. | 0.84% | 2,122,605 | $3.8M | No change |
| TSHA Taysha Gene Therapies Inc. | 0.52% | 724,873 | $2.4M | No change |
| CADL Candel Therapeutics Inc. | 0.45% | 405,837 | $2.1M | No change |
| FIG Figma Inc. Class A | 0.21% | 18,286 | $948K | New |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 24 | $613.5M | ALMR, NU, KVYO, BBNX, SGP |
| Q1 2026 | 21 | $421.2M | NU, KVYO, SGP, BBNX, IKT |
| Q4 2025 | 20 | $518.5M | KVYO, NU, BBNX, IKT, DASH |
| Q3 2025 | 20 | $456.4M | NU, KVYO, BBNX, CPNG, DASH |
| Q2 2025 | 19 | $507.8M | KVYO, NU, DASH, BBNX, CPNG |
| Q1 2025 | 20 | $408.9M | KVYO, NU, DASH, BBNX, IKT |
| Q4 2024 | 21 | $459.7M | KVYO, NU, DASH, IKT, CPNG |
| Q3 2024 | 20 | $355.8M | KVYO, NU, DASH, BIOA, ACRV |
| Q2 2024 | 20 | $298.6M | NU, KVYO, DASH, PATH, SNOW |
| Q1 2024 | 20 | $414.7M | NU, KVYO, DASH, PATH, SNOW |